{{Rsnum
|rsid=110419
|Gene=LMO1
|Chromosome=11
|position=8231306
|Orientation=plus
|GMAF=0.4054
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=LMO1
}}[[rs110419]] is a SNP in the [[LMO1]]  LIM domain only 1 (rhombotin 1) gene.

A GWAS study of 2,000+ patients (and 6,000+ controls) concluded that the [[rs110419]](A) allele is associated with increased risk for [[neuroblastoma]], with an allelic odds ratio of 1.34 (CI: 1.25–1.44, combined p = 5.2?×?10e?16).{{PMID|21124317|OA=1
}}

{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 26.5 | 47.8 | 25.7
| HCB | 30.7 | 49.6 | 19.7
| JPT | 40.7 | 48.7 | 10.6
| YRI | 66.0 | 31.3 | 2.7
| ASW | 61.4 | 33.3 | 5.3
| CHB | 30.7 | 49.6 | 19.7
| CHD | 32.1 | 45.9 | 22.0
| GIH | 5.9 | 35.6 | 58.4
| LWK | 74.5 | 22.7 | 2.7
| MEX | 17.2 | 51.7 | 31.0
| MKK | 50.6 | 39.1 | 10.3
| TSI | 14.7 | 57.8 | 27.5
| HapMapRevision=28
}}

{{PMID Auto
|PMID=18463370
|Title=Chromosome 6p22 locus associated with clinically aggressive neuroblastoma.
|OA=1
}}

{{PMID Auto GWAS
  |PMID=22941191
  |Trait=Neuroblastoma
  |Title=Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma.
  |RiskAllele=A
  |Pval=1E-13
  |OR=1.32
  |ORtxt=[NR]
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}